Misuse of Drugs Act 1975

Schedule 2
Class B controlled drugs

s 2(1)

Part 1

1 The following substances, namely:

  • Amphetamine (2-amino-1-phenylpropane)

    Cannabis preparations: that is, any preparation containing any tetrahydrocannabinols, including cannabis resin (commonly known as hashish) and cannabis oil (commonly know as hash oil), produced by subjecting cannabis plant material to any kind of processing

    MDMA (2-methylamino-1-(3,4-methylenedioxyphenyl) propane)

    Methcathinone

    Morphine

    Opium

    Tetrahydrocannabinols, except when contained in a Class C controlled drug.

    Schedule 2 Part 1 clause 1 Amphetamine: inserted, on 9 September 2005, by clause 4(1) of the Misuse of Drugs (Changes to Controlled Drugs) Order 2005 (SR 2005/175).

    Schedule 2 Part 1 clause 1 Cannabis: substituted, on 13 January 1983, by section 7 of the Misuse of Drugs Amendment Act 1982 (1982 No 151).

    Schedule 2 Part 1 clause 1 Cocaine: repealed, on 13 January 1988, by section 9(1) of the Misuse of Drugs Amendment Act (No 2) 1987 (1987 No 193).

    Schedule 2 Part 1 clause 1 MDMA: inserted, on 9 September 2005, by clause 4(1) of the Misuse of Drugs (Changes to Controlled Drugs) Order 2005 (SR 2005/175).

    Schedule 2 Part 1 clause 1 Methcathinone: inserted, on 30 May 2003, by clause 5(1) of the Misuse of Drugs (Changes to Controlled Drugs) Order 2003 (SR 2003/47).

    Schedule 2 Part 1 clause 1 Tetrahydrocannabinols: added, on 2 September 1996, by section 7(1) of the Misuse of Drugs Amendment Act 1996 (1996 No 133).

2

  • The isomers of the substances mentioned in clause 1 whenever the existence of such isomers is possible within the specific chemical designation.

    Schedule 2 Part 1 clause 2: amended, on 31 May 2002, by clause 3(2)(a) of the Misuse of Drugs (Classification of Fantasy) Order 2001 (SR 2001/383).

3

  • The esters and ethers of the substances mentioned in clause 1 and the esters and ethers of the isomers mentioned in clause 2 whenever the existence of such esters or ethers is possible.

    Schedule 2 Part 1 clause 3: amended, on 31 May 2002, by clause 3(2)(b) of the Misuse of Drugs (Classification of Fantasy) Order 2001 (SR 2001/383).

4

  • The salts of the substances mentioned in clause 1 and the salts of the isomers, esters, and ethers mentioned in clause 2 or clause 3.

    Schedule 2 Part 1 clause 4: amended, on 31 May 2002, by clause 3(2)(c) of the Misuse of Drugs (Classification of Fantasy) Order 2001 (SR 2001/383).

5
6

  • The substance gamma-hydroxybutyrate (GHB) (commonly known as fantasy) and—

    • (a) the esters, ethers, and amides of GHB; and

    • (b) all substances from which GHB can be derived, including (without limitation)—

      • (i) 1,4-butanediol:

      • (ii) gamma-aminobutyric acid:

      • (iii) gamma-butyrolactone:

      • (iv) gamma-hydroxybutyraldehyde; and

    • (c) the salts of GHB (including sodium oxybate) and the salts of any substance referred to in paragraph (a) or paragraph (b); and

    • (d) any substance, preparation, or mixture containing any proportion of GHB or any substance referred to in any of paragraphs (a) to (c).

    Schedule 2 Part 1 clause 6: added, on 31 May 2002, by clause 3(1) of the Misuse of Drugs (Classification of Fantasy) Order 2001 (SR 2001/383).

Part 2

1 The following substances, namely:

  • Benzphetamine (2-benzylmethylamino-1-phenylpropane)

    Cathinone (2-amino-1-phenylpropan-1-one)

    DOET (2-amino-1-(2,5-dimethoxy-4-ethylphenyl) propane)

    Ephedrine

    N-ethyl MDA (2-ethylamino-1-(3,4-methylenedioxyphenyl) propane)

    N-ethylamphetamine (2-ethylamino-1-phenylpropane)

    Fencamfamine (N-ethyl-3-phenylbicyclo[2.2.1]heptan-2-amine)

    Fenethylline (3,7-dihydro-1,3-dimethyl-7-[2-[(1-methyl-2-phenylethyl)-amino]ethyl]-1H-purine-2,6-dione)

    Fenproporex (2-(2-cyanoethylamino)-1-phenylpropane)

    N-hydroxy MDA (2-hydroxyamino-1-(3,4-methylenedioxyphenyl) propane)

    Mefenorex (2-(3-chloropropylamino)-1-phenylpropane)

    Methaqualone (2-methyl-3-(2-methylphenyl)-4(3H)-quinazolinone)

    4-methylaminorex (cis-2-amino-4-methyl-5-phenyl-2-oxazoline)

    Methylphenidate (α-phenyl-2-piperidineacetic acid methyl ester)

    4-methylthioamphetamine

    Norpseudoephedrine (threo-2-amino-1-hydroxy-1-phenylpropane), including cathine

    Propylhexedrine (1-cyclohexyl-2-methylaminopropane)

    Pseudoephedrine

    Pyrovalerone (1-(4-methylphenyl)-2-(1-pyrrolidinyl)-1-pentanone).

    Schedule 2 Part 2 clause 1: substituted, on 13 January 1988, by section 9(2) of the Misuse of Drugs Amendment Act (No 2) 1987 (1987 No 193).

    Schedule 2 Part 2 clause 1 Amphetamine: repealed, on 9 September 2005, by clause 4(2) of the Misuse of Drugs (Changes to Controlled Drugs) Order 2005 (SR 2005/175).

    Schedule 2 Part 2 clause 1 Ephedrine: inserted, on 8 September 2011, by section 8 of the Misuse of Drugs Amendment Act (No 2) 2011 (2011 No 54).

    Schedule 2 Part 2 clause 1 N-ethyl MDA: inserted, on 2 September 1996, by section 7(3) of the Misuse of Drugs Amendment Act 1996 (1996 No 133).

    Schedule 2 Part 2 clause 1 N-hydroxy MDA: inserted, on 2 September 1996, by section 7(3) of the Misuse of Drugs Amendment Act 1996 (1996 No 133).

    Schedule 2 Part 2 clause 1 MDMA: repealed, on 9 September 2005, by clause 4(2) of the Misuse of Drugs (Changes to Controlled Drugs) Order 2005 (SR 2005/175).

    Schedule 2 Part 2 clause 1 Methamphetamine: repealed, on 30 May 2003, by clause 5(2) of the Misuse of Drugs (Changes to Controlled Drugs) Order 2003 (SR 2003/47).

    Schedule 2 Part 2 clause 1 4-methylaminorex: inserted, on 2 September 1996, by section 7(3) of the Misuse of Drugs Amendment Act 1996 (1996 No 133).

    Schedule 2 Part 2 clause 1 4-methylthioamphetamine: inserted, on 30 May 2003, by clause 5(3) of the Misuse of Drugs (Changes to Controlled Drugs) Order 2003 (SR 2003/47).

    Schedule 2 Part 2 clause 1 Norpseudoephedrine: substituted, on 2 September 1996, by section 7(2) of the Misuse of Drugs Amendment Act 1996 (1996 No 133).

    Schedule 2 Part 2 clause 1 Pseudoephedrine: inserted, on 8 September 2011, by section 8 of the Misuse of Drugs Amendment Act (No 2) 2011 (2011 No 54).

2

  • The isomers of the substances mentioned in this Part whenever the existence of such isomers is possible within the specific chemical designation.

3

  • The esters and ethers of the substances mentioned in this Part and the esters and ethers of the isomers mentioned in clause 2 whenever the existence of such esters or ethers is possible.

4

  • The salts of the substances mentioned in this Part and the salts of the isomers, esters, and ethers mentioned in clause 2 or clause 3.

5

Part 3

1 The following substances, namely:

  • Acetyl-α-methylfentanyl (N-[1-(α-methylphenethyl]-4-piperidyl] acetanilide)

    Acetylmethadol (3-acetoxy-6-dimethylamino-4,4-diphenylheptane)

    Alfentanil (N-[1-[2-(4-ethyl-4,5-dihydro-5-oxo-1H-(tetrazol-1-yl)ethyl]-4-(methoxymethyl)-4-piperidinyl]-N-phenylpropanamide)

    Allylprodine (3-allyl-1-methyl-4-phenyl-4-propionoxypiperidine)

    Alphacetylmethadol (α-3-acetoxy-6-dimethylamino-4,4-diphenylheptane)

    Alphameprodine (α-3-ethyl-1-methyl-4-phenyl-4-propionoxypiperidine)

    Alphamethadol (α-6-dimethylamino-4,4-diphenyl-3-heptanol)

    Alphaprodine (α-1,3-dimethyl-4-phenyl-4-propionoxypiperidine)

    Anileridine (1-para-aminophenethyl-4-phenylpiperidine-4-carboxylic acid ethyl ester)

    Benzethidine (1-(2-benzyloxyethyl)-4-phenylpiperidine-4-carboxylic acid ethyl ester)

    Benzylmorphine (3-benzylmorphine)

    Betacetylmethadol (β-3-acetoxy-6-dimethylamino-4,4-diphenylheptane)

    Betameprodine (β-3-ethyl-1-methyl-4-phenyl-4-propionoxypiperidine)

    Betamethadol (β-6-dimethylamino-4,4-diphenyl-3-heptanol)

    Betaprodine (β-1,3-dimethyl-4-phenyl-4-propionoxypiperidine)

    Bezitramide (1-(3-cyano-3,3-diphenylpropyl)-4-(2-oxo-3-propionyl-1-benzimidazolinyl)piperidine)

    Clonitazene (2-para-chlorbenzyl-1-diethylaminoethyl-5-nitrobenzimidazole)

    Codoxime (dihydrocodeinone-6-carboxymethyloxime)

    Concentrate of poppy straw—that is, the material arising when parts of any plant of the species Papaver somniferum have entered a process for the concentration of the alkaloids

    Dextromoramide ((+)-4-[2-methyl-4-oxo-3,3-diphenyl-4-(1-pyrrolidinyl) butyl] morpholine)

    Diampromide (N-[2-(methylphenethylamino) propyl] propionanilide)

    Diethylthiambutene (3-diethylamino-1,1-di-(2′-thienyl)-1-butene).

    Difenoxin (1-(3-cyano-3, 3 diphenylpropyl)-4-phenylisonipecotic acid)

    Dihydromorphine

    Dimenoxadol (2-dimethylaminoethyl 1-ethoxy-1, 1-diphenylacetate)

    Dimepheptanol (6-dimethylamino-4,4-diphenyl-3-heptanol)

    Dimethylthiambutene (3-dimethylamino-1,1-di-(2′-thienyl)-1-butene)

    Dioxaphetyl butyrate (ethyl 4-morpholino-2, 2-diphenylbutyrate)

    Diphenoxylate (1-(3-cyano-3,3-diphenylpropyl)-4-phenylpiperidine-4-carboxylic acid ethyl ester)

    Dipipanone (4,4-diphenyl-6-piperidine-3-heptanone)

    Drotebanol (3,4-dimethoxy-17-methylmorphinan-6β, 14-diol)

    Ecgonine, its esters and derivatives which are convertible to ecgonine and cocaine, except when contained in a Class C controlled drug

    Ethylmethylthiambutene (3-ethylmethylamino-1,1-di-(2′-thienyl)-1-butene)

    Etonitazene (1-diethylaminoethyl-2-para-ethoxybenzyl-5-nitrobenzimidazole)

    Etoxeridine (1-[2-(2-hydroxyethoxy)ethyl]-4-phenylpiperidine-4-carboxylic acid ethyl ester)

    Fentanyl (1-phenethyl-4-(N-propionylanilino)piperidine)

    p-fluorofentanyl (4′-fluoro-N-1-(phenethyl-4-piperidyl) propionanilide)

    Furethidine (1-(2-tetrahydrofurfuryloxyethyl)-4-phenylpiperidine-4-carboxylic acid ethyl ester)

    Hydrocodone (dihydrocodeinone)

    Hydromorphinol (14-hydroxydihydromorphine)

    Hydromorphone (dihydromorphinone)

    β-hydroxyfentanyl (N-[1-(β-hydroxyphenethyl)-4-piperidyl] propionanilide)

    β-hydroxy-3-methylfentanyl (N-[1-(β-hydroxyphenethyl)-3-methyl-4-piperidyl]propionanilide)

    Hydroxypethidine (4-meta-hydroxyphenyl-1-methylpiperidine-4-carboxylic acid ethyl ester)

    Isomethadone (6-dimethylamino-5-methyl-4,4-diphenyl-3-hexanone)

    Levomethorphan ((−)-3-methoxy-N-methylmorphinan) but not including dextromethorphan ((+)-3-methoxy-N-methylmorphinan) and dextrorphan ((+)-3-hydroxy-N-methylmorphinan)

    Levomoramide ((−)-4-[2-methyl-4-oxo-3,3-diphenyl-4-(1-pyrrolidinyl) butyl] morpholine)

    Levophenacylmorphan ((−)-3-hydroxy-N-phenacylmorphinan)

    Levorphanol ((−)-3-hydroxy-N-methylmorphinan)

    Mecloqualone (3-(2-chlorophenyl)-2-methyl-4-(3H)-quinazolinone)

    Metazocine (2′-hydroxy-2,5,9-trimethyl-6,7-benzomorphan)

    Methadone (6-dimethylamino-4,4-diphenyl-3-heptanone)

    Methadone-intermediate (4-cyano-2-dimethylamino-4,4-diphenylbutane)

    1-methyl-4-phenyl-4-piperidinol

    Methyldesorphine (6-methyl-Δ6-deoxymorphine)

    Methyldihydromorphine (6-methyldihydromorphine)

    α-methylfentanyl (N-[1-(α-methylphenethyl)-4-piperidyl]propionanilide)

    3-methylfentanyl (N-[3-methyl-1-phenethyl-4-piperidyl] propionanilide)

    α-methylthiofentanyl (N-[1-[1-methyl-2-(2-thienyl)ethyl]-4-piperidyl]propionanilide)

    3-methylthiofentanyl (N-[3-methyl-1-[2-(2-thienyl)ethyl]-4-piperidyl]propionanilide)

    Metopon (5-methyldihydromorphinone)

    Moramide-intermediate (2-methyl-3-morpholino-1,1-diphenylpropane carboxylic acid)

    Morpheridine (1-(2-morpholinoethyl)-4-phenylpiperidine-4-carboxylic acid ethyl ester)

    Morphine methobromide and other pentavalent nitrogen morphine derivatives

    Morphine-n-oxide

    MPPP (1-methyl-4-phenyl-4-piperidinol propionate (ester))

    Myrophine (myristylbenzylmorphine)

    Nabilone (trans-3-(1-1-dimethylheptyl)-6,6a,7,8,10,10a-hexahydro-1-hydroxy-6, 6-dimethyl-9H-dibenzo[b,d] pyran-9-one)

    Nicomorphine (3,6-dinicotinylmorphine)

    Noracymethadol (α-3-acetoxy-6-methylamino-4,4-diphenylheptane)

    Norlevorphanol ((−)-3-hydroxymorphinan)

    Normethadone (6-dimethylamino-4,4-diphenyl-3-hexanone)

    Normorphine (demethylmorphine)

    Norpipanone (4,4-diphenyl-6-piperidino-3-hexanone)

    Oxycodone (14-hydroxydihydrocodeinone)

    Oxymorphone (14-hydroxydihydromorphinone)

    PEPAP (1-phenethyl-4-phenyl-4-piperidinol acetate (ester))

    Pethidine (1-methyl-4-phenylpiperidine-4-carboxylic acid ethyl ester)

    Pethidine-intermediate-A (4-cyano-1-methyl-4-phenylpiperidine)

    Pethidine-intermediate-B (4-phenylpiperidine-4-carboxylic acid ethyl ester)

    Pethidine-intermediate-C (1-methyl-4-phenylpiperidine-4-carboxylic acid)

    Phenadoxone (6-morpholino-4,4diphenyl-3-heptanone)

    Phenampromide (N-(1-methyl-2-piperidinoethyl) propionanilide)

    Phenazocine (2′-hydroxy-5,9-dimethyl-2-phenethyl-6,7-benzomorphan)

    Phendimetrazine (3,4-dimethyl-2-phenylmorpholine)

    1-phenethyl-4-phenyl-4-piperidinol.

    Phenmetrazine (3-methyl-2-phenylmorpholine)

    Phenomorphan (3-hydroxy-N-phenethylmorphinan)

    Phenoperidine (1-(3-hydroxy-3-phenylpropyl)-4-phenylpiperidine-4-carboxylic acid ethyl ester)

    Piminodine (4-phenyl-1-(3-phenylaminopropyl)piperidine-4-carboxylic acid ethyl ester)

    Piritramide (1-(3-cyano-3,3-diphenylpropyl)-4-(1-piperidino) piperidine-4-carboxylic acid amide)

    Proheptazine (1,3-dimethyl-4-phenyl-4-propionoxyazacycloheptane)

    Properidine (1-methyl-4-phenylpiperidine-4-carboxylic acid isopropyl ester)

    Racemethorphan ((±)-3-methoxy-N-methylmorphinan)

    Racemoramide ((±) -4- [2-methyl-4-oxo-3, 3-diphenyl-4-(1-pyrrolidinyl) butyl] morpholine)

    Racemorphan ((±)-3-hydroxy-N-methylmorphinan)

    Remifentanil (1-(2-methoxycarbornyl-ethyl)-4-(phenylpropionyl-amino)-piperidine-4-carboxylic acid methyl ester)

    Sufentanil (N-[4-(methoxymethyl)-1-[2-(2-thienyl)ethyl]-4-piperidyl] propionanilide)

    Tapentadol (3-[(1R,2R)-3-(dimethylamino)-1-ethyl-2-methylpropyl]phenol hydrochloride)

    Thebacon (acetyldihydrocodeinone)

    Thebaine

    Thiofentanyl (N-[1-[2-(2-thienyl)ethyl]-4-piperidyl]propionanilide)

    Tilidine ((±)-ethyl trans-2-(dimethylamino)-1-phenyl-3-cyclohexene-1-carboxylate)

    Trimeperidine (1,2,5-trimethyl-4-phenyl-4-propionoxypiperidine).

    Schedule 2 Part 3 clause 1 Acetyl-α-methylfentanyl: inserted, on 2 September 1996, by section 7(4) of the Misuse of Drugs Amendment Act 1996 (1996 No 133).

    Schedule 2 Part 3 clause 1 Alfentanil: inserted, on 6 November 1986, by section 4 of the Misuse of Drugs Amendment Act 1986 (1986 No 102).

    Schedule 2 Part 3 clause 1 p-fluorofentanyl: inserted, on 2 September 1996, by section 7(4) of the Misuse of Drugs Amendment Act 1996 (1996 No 133).

    Schedule 2 Part 3 clause 1 β-hydroxyfentanyl: inserted, on 2 September 1996, by section 7(4) of the Misuse of Drugs Amendment Act 1996 (1996 No 133).

    Schedule 2 Part 3 clause 1 β-hydroxy-3-methylfentanyl: inserted, on 2 September 1996, by section 7(4) of the Misuse of Drugs Amendment Act 1996 (1996 No 133).

    Schedule 2 Part 3 clause 1 Mecloqualone: inserted, on 21 May 1981, by clause 3(2) of the Misuse of Drugs Order 1981 (SR 1981/114).

    Schedule 2 Part 3 clause 1 1-methyl-4-phenyl-4-piperidinol: inserted, on 2 September 1996, by section 7(4) of the Misuse of Drugs Amendment Act 1996 (1996 No 133).

    Schedule 2 Part 3 clause 1 α-methylfentanyl: inserted, on 2 September 1996, by section 7(4) of the Misuse of Drugs Amendment Act 1996 (1996 No 133).

    Schedule 2 Part 3 clause 1 3-methylfentanyl: inserted, on 2 September 1996, by section 7(4) of the Misuse of Drugs Amendment Act 1996 (1996 No 133).

    Schedule 2 Part 3 clause 1 α-methylthiofentanyl: inserted, on 2 September 1996, by section 7(4) of the Misuse of Drugs Amendment Act 1996 (1996 No 133).

    Schedule 2 Part 3 clause 1 3-methylthiofentanyl: inserted, on 2 September 1996, by section 7(4) of the Misuse of Drugs Amendment Act 1996 (1996 No 133).

    Schedule 2 Part 3 clause 1 MPPP: inserted, on 2 September 1996, by section 7(4) of the Misuse of Drugs Amendment Act 1996 (1996 No 133).

    Schedule 2 Part 3 clause 1 Nabilone: inserted, on 13 January 1988, by section 9(3) of the Misuse of Drugs Amendment Act (No 2) 1987 (1987 No 193).

    Schedule 2 Part 3 clause 1 PEPAP: inserted, on 2 September 1996, by section 7(4) of the Misuse of Drugs Amendment Act 1996 (1996 No 133).

    Schedule 2 Part 3 clause 1 1-phenethyl-4-phenyl-4-piperidinol: inserted, on 2 September 1996, by section 7(4) of the Misuse of Drugs Amendment Act 1996 (1996 No 133).

    Schedule 2 Part 3 clause 1 Remifentanil: inserted, on 2 September 1996, by section 7(4) of the Misuse of Drugs Amendment Act 1996 (1996 No 133).

    Schedule 2 Part 3 clause 1 Sufentanil: inserted, on 21 May 1981, by clause 3(2) of the Misuse of Drugs Order 1981 (SR 1981/114).

    Schedule 2 Part 3 clause 1 Tapentadol: inserted, on 1 May 2012, by clause 3 of the Misuse of Drugs (Classification of Tapentadol) Order 2011 (SR 2011/247).

    Schedule 2 Part 3 clause 1 Thiofentanyl: inserted, on 2 September 1996, by section 7(4) of the Misuse of Drugs Amendment Act 1996 (1996 No 133).

    Schedule 2 Part 3 clause 1 Tilidine: inserted, on 21 May 1981, by clause 3(2) of the Misuse of Drugs Order 1981 (SR 1981/114).

2

  • The isomers of the substances mentioned in this Part whenever the existence of such isomers is possible within the specific chemical designation.

3

  • The esters and ethers of the substances mentioned in this Part and the esters and ethers of the isomers mentioned in clause 2 whenever the existence of such esters or ethers is possible.

4

  • The salts of the substances mentioned in this Part and the salts of the isomers, esters, and ethers mentioned in clause 2 or clause 3.

5